PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
21-Nov-2023 UK Medical Devices Regulations: TÜV Rheinland is now a UK Approved Body according to UK MDR TÜV Rheinland
21-Nov-2023 Myricx Bio Enters into an Exclusive Antibody License Agreement with WuXi Biologics Myricx Bio
21-Nov-2023 Vironova BioAnalytics AB Acquired by an investor syndicate, led by Quatre Lab, to expand its TEM services for the pharmaceutical industry; to be rebranded as QuTEM Vironova BioAnalytics
21-Nov-2023 EDX MEDICAL & THERMO FISHER SCIENTIFIC TO COLLABORATE ON DEVELOPMENT OF INNOVATIVE CANCER TESTS FOR GLOBAL MARKETS EDX Medical Group plc
21-Nov-2023 Kaleido launches cutting-edge Hybrid Closed Loop system with Diabeloop and Dexcom for people with diabetes ViCentra B.V.
20-Nov-2023 Omnix Medical Receives U.S. FDA Approval of a Phase II Trial of its Next-Generation Anti-Infective OMN6 Omnix Medical
17-Nov-2023 CluePoints wins SCRIP Awards for Best Contract Research Organization (CRO): Specialist Providers CluePoints
17-Nov-2023 Karuna Therapeutics Announces Positive Results from Phase 1b Ambulatory Blood Pressure Monitoring Trial of KarXT in Schizophrenia Karuna Therapeutics
17-Nov-2023 Minoryx announces enrollment of first patients with cerebral Adrenoleukodystrophy (cALD) in US Phase 3 clinical trial, CALYX Minoryx
17-Nov-2023 UK industry clinical trial performance shows signs of improvement, says ABPI report ABPI
15-Nov-2023 Landmark Clinical Trial Redefines Multidrug-Resistant Tuberculosis Treatment Options Médecins Sans Frontières/ MSF's
15-Nov-2023 SciRhom Files Clinical Trial Application for First-in-Human Trials of Novel Antibody Against Autoimmune Diseases SciRhom
14-Nov-2023 Glox Therapeutics Secures £4.3M Seed Funding to Develop Precision Antimicrobials Targeting Drug-resistant Bacteria Glox Therapeutics
14-Nov-2023 PureTech's LYT-300 (Oral Allopregnanolone) Achieved Primary Endpoint in a Phase 2a Acute Anxiety Trial in Healthy Volunteers PureTech Health plc
14-Nov-2023 The Revolutionary Era of Liquid Biopsy: A Non-Invasive Approach to Precision Medicine Roots Analysis
13-Nov-2023 Bloomsbury Genetic Therapies Celebrates its One Year Anniversary and Outlines Key Strategic and Operational Achievements since Launch Bloomsbury Genetic Therapies
13-Nov-2023 Resolution Therapeutics’ founders present clinical proof-of-concept for macrophage cell therapy in end-stage liver disease at AASLD Resolution Therapeutics Limited
09-Nov-2023 Phesi launches Patient Access Score for clinical trial sponsors to enhance investigator selection and accelerate patient recruitment Phesi
09-Nov-2023 Lindus Health and Pharmanovia announce enrolment of first patient in new clinical trial to explore the treatment of severe insomnia in hard-to-reach patients Lindus Health and Pharmanovia
09-Nov-2023 Lytix Biopharma presents third quarter 2023 results Lytix